Home / Toolkit
New drug development
Sep
2021
2021
Xiong Y, Li NX, Duan N, Liu B, Zhu H, Zhang C, Li L, Lu C, Huang L. Traditional Chinese Medicine in Treating Influenza: From Basic Science to Clinical Applications. Front Pharmacol. 2020 Sep 15;11:575803. doi: 10.3389/fphar.2020.575803. PMID: 33041821; PMCID: PMC7526665.
Jan
2020
2020
Shi N, Guo L, Liu B, Bian Y, et al. Efficacy and safety of Chinese herbal medicine versus Lopinavir-Ritonavir in adult patients with coronavirus disease 2019: A non-randomized controlled trial. Phytomedicine. 2021 Jan;81:153367. doi: 10.1016/j.phymed.2020.153367. Epub 2020 Oct 8. PMID: 33260064; PMCID: PMC7543765.
May
2021
2021
Xiong Y, Ma Y, Tian Y, Zhang C, Yang W, Liu B, Ruan L, Lu C, Huang L. A Longitudinal Cohort Study Using a Modified Child-Pugh Score to Escalate Respiratory Support in COVID-19 Patients - Hubei Province, China, 2020. China CDC Wkly. 2021 May 14;3(20):423-429. doi: 10.46234/ccdcw2021.113. PMID: 34594905; PMCID: PMC8392970.
Sep
2021
2021
Wang Y, Lu C, Li H, Q, et al. Efficacy and safety assessment of severe COVID-19 patients with Chinese medicine: A retrospective case series study at early stage of the COVID-19 epidemic in Wuhan, China. J Ethnopharmacol. 2021 Sep 15;277:113888. doi: 10.1016/j.jep.2021.113888. Epub 2021 Jan 30. PMID: 33529638; PMCID: PMC7847283.
Sep
2021
2021
Zhao C, Li L, Yang W, Lv W, et al. Chinese Medicine Formula Huashibaidu Granule Early Treatment for Mild COVID-19 Patients: An Unblinded, Cluster-Randomized Clinical Trial. Front Med (Lausanne). 2021 Sep 16;8:696976. doi: 10.3389/fmed.2021.696976. PMID: 34604251; PMCID: PMC8481869.
Oct
2021
2021
Liu J, Yang W, Liu Y, et al. Combination of Hua Shi Bai Du granule (Q-14) and standard care in the treatment of patients with coronavirus disease 2019 (COVID-19): A single-center, open-label, randomized controlled trial. Phytomedicine. 2021 Oct;91:153671. doi: 10.1016/j.phymed.2021.153671. Epub 2021 Jul 17. PMID: 34425471; PMCID: PMC8285932.
Dec
2021
2021
Xiong YB, Tian YX, Ma Y, Yang W, Liu B, Ruan LG, Lu C, Huang LQ. Factors Defining the Development of Severe Illness in Patients with COVID-19: A Retrospective Study. Biomed Environ Sci. 2021 Dec 20;34(12):984-991. doi: 10.3967/bes2021.117. PMID: 34981721; PMCID: PMC8747433.
Jan
2022
2022
Xiong Y, Tian Y, Ma Y, Liu B, Ruan L, Lu C, Huang L; National Traditional Chinese Medicine Medical Team. The effect of Huashibaidu formula on the blood oxygen saturation status of severe COVID-19: A retrospective cohort study. Phytomedicine. 2022 Jan;95:153868. doi: 10.1016/j.phymed.2021.153868. Epub 2021 Dec 3. PMID: 34929564; PMCID: PMC8641428.
Feb
2022
2022
Xiong Y, Ma Y, Ruan L, Li D, Lu C, Huang L; National Traditional Chinese Medicine Medical Team. Comparing different machine learning techniques for predicting COVID-19 severity. Infect Dis Poverty. 2022 Feb 17;11(1):19. doi: 10.1186/s40249-022-00946-4. PMID: 35177120; PMCID: PMC8851750.
Jul
2024
2024
GUO Jing, CHE Qianzi, LI Huizhen, et al. Research Strategies and Key Points of Traditional Chinese Medicine Theory in Compound Chinese Medicine Preparations under the “Three-Combination” Evaluation Evidence System. Chinese Journal of Basic Medicine In Traditional Chinese Medicine.2024,30(07):1152-1155.DOI:10.19945/j.cnki.issn.1006-3250.2024.07.010.
Jul
2024
2024
CHEN Lin, GUO Jing, CHE Qianzi, et al. Discussion on Traditional Chinese Medicine Theoretical Research of New Drugs Derived from Ancient Classical Formulas Based on the “Four Anti-Epidemic Formulas”.Chinese Journal of Basic Medicine In Traditional Chinese Medicine,2024,30(07):1161-1166.DOI:10.19945/j.cnki.issn.1006-3250.2024.07.014.
Jul
2024
2024
GUO Jing, CHE Qianzi, LI Huizhen, et al. Reflections on Establishing the Functions and Indications of Modified Ancient Classical Formulas Based on Traditional Chinese Medicine Theory. Chinese Journal of Basic Medicine In Traditional Chinese Medicine,2024,30(07):1156-1160.DOI:10.19945/j.cnki.issn.1006-3250.2024.07.012.
Aug
2024
2024
GUO Jing, CHEN Lin, TONG Lin, et al. Reflections and Recommendations on the Clinical Positioning of New Chinese Medicines under the 'Three-Combination' Evaluation Evidence System. Chinese Journal of Basic Medicine In Traditional Chinese Medicine,2024,30(08):1331-1336.DOI:10.19945/j.cnki.issn.1006-3250.2024.08.013.
Aug
2024
2024
CHE Qianzi, GUO Jing, TONG Lin, et al. Research Strategies and Methods for Clinical Positioning of New Chinese Medicines Based on Human Experience.Chinese Journal of Basic Medicine In Traditional Chinese Medicine,2024,30(08):1337-1340.DOI:10.19945/j.cnki.issn.1006-3250.2024.08.011.
Aug
2024
2024
CHEN Lin, GUO Jing, CHE Qianzi, et al. Discussion on the Clinical Positioning of New Chinese Medicines Based on Marketed Similar Products.Chinese Journal of Basic Medicine In Traditional Chinese Medicine,2024,30(08):1341-1343.DOI:10.19945/j.cnki.issn.1006-3250.2024.08.007.
Sep
2024
2024
MU Tingting, HU Nina, DU Song, et al. Analysis of the Second Batch of Classical Formulas and Related Theoretical Research Strategies.Chinese Journal of Basic Medicine In Traditional Chinese Medicine,2024,30(09):1486-1494.DOI:10.19945/j.cnki.issn.1006-3250.2024.09.007.
Sep
2024
2024
CHE Qianzi, TONG Lin, ZHANG Huamin, et al. Key Points in Designing Clinical Research Based on Human Experience for the Development of New Chinese Medicines.Chinese Journal of Basic Medicine In Traditional Chinese Medicine,2024,30(09):1495-1499.DOI:10.19945/j.cnki.issn.1006-3250.2024.09.002.
Sep
2024
2024
XU Hui, HU Nina, LIU Chenxi, et al. Analysis of the Selection and Development Strategies of Classic Old Medicines Based on Marketed Chinese Patent Medicines.Chinese Journal of Basic Medicine In Traditional Chinese Medicine,2024,30(09):1481-1485.DOI:10.19945/j.cnki.issn.1006-3250.2024.09.004.
Dec
2024
2024
CHE Qianzi, ZHANG Zhiqing, LIU Bin, et al. Machine Learning to Enhance Real-World Research in Traditional Chinese Medicine: A New Method for Secondary Development of Chinese Medicines.Chinese Journal of Basic Medicine In Traditional Chinese Medicine,1-12[2025-03-31].https://doi.org/10.19945/j.cnki.issn.1006-3250.20241230.003.
Dec
2024
2024
CAO Wenjie,YANG Yijiu,WANG Weili,et al. Exploration of Multi-dimensional Integration Method of Clinical Accurate Positioning of Chinese Patent Medicine Based on Clinical Comprehensive Evaluation. Chinese Journal of Basic Medicine In Traditional Chinese Medicine,1-12[2025-03-31].https://doi.org/10.19945/j.cnki.issn.1006-3250.20241230.001.
Dec
2024
2024
ZHANG Haili, CAO Wenjie, CHE Qianzi, et al. Research on the Path of Secondary Development of Chinese Patent Medicines Based on Comprehensive Clinical Evaluation of Pharmaceuticals.Chinese Journal of Basic Medicine In Traditional Chinese Medicine,1-10[2025-03-31].https://doi.org/10.19945/j.cnki.issn.1006-3250.20241230.004.
Dec
2024
2024
GUO Jing, CHEN Lin, GONG Zhaoyuan, et al. Exploration of the Research and Development Model for Indication Repositioning of Chinese Patent Medicines Based on Multi-dimensional Biological Network Associations Under the Concept of Treating Different Diseases with the Same Method. Chinese Journal of Basic Medicine In Traditional Chinese Medicine,1-6[2025-03-31].https://doi.org/10.19945/j.cnki.issn.1006-3250.20241230.005.
Dec
2024
2024
CHEN Lin, GUO Jing, LIU Bin, et al. Analysis and Implementation Strategies of the Research and Development Model for Modified New Chinese Medicines.Chinese Journal of Basic Medicine In Traditional Chinese Medicine,1-13[2025-03-31].https://doi.org/10.19945/j.cnki.issn.1006-3250.20241230.006.
Dec
2024
2024
CHE Qianzi, CHEN Lin, ZHANG Haili, et al. New Opportunities in Chinese Medicine Research and Development: Drug Repositioning Strategies Based on Multi-Omics Research.Chinese Journal of Basic Medicine In Traditional Chinese Medicine,1-11[2025-03-31].https://doi.org/10.19945/j.cnki.issn.1006-3250.20241230.002.
Jan
2025
2025
GUO Jing, LIU Bin, CHEN Lin, et al. Exploration of the Application of Core Symptom Groups in the Development of New Chinese Medicines Based on the Theory of Differentiation of Mechanism and Treatment. Chinese Journal of Basic Medicine In Traditional Chinese Medicine,1-6[2025-03-31].https://doi.org/10.19945/j.cnki.issn.1006-3250.20250103.003.
Jan
2025
2025
CHE Qianzi, TONG Lin, ZHANG Huamin, et al. Technical System Framework for Traditional Chinese Medicine Theory Research in New Chinese Medicines under the 'Three-Combination' Evaluation Evidence System.Chinese Journal of Basic Medicine In Traditional Chinese Medicine,1-12[2025-03-31].https://doi.org/10.19945/j.cnki.issn.1006-3250.20250103.001.
Jan
2025
2025
GUO Jing, CHEN Lin, LI Huizhen, et al. Discussion on Key Issues in the Development of Ancient Classical Formulas Under the Background of Integrative Medicine.Chinese Journal of Basic Medicine In Traditional Chinese Medicine,1-6[2025-03-31].https://doi.org/10.19945/j.cnki.issn.1006-3250.20250103.002.
Jan
2025
2025
CHEN Lin, GUO Jing, LIU Bin, et al. Method for Analyzing and Verifying the Sources of Formulas in Compound Chinese Medicine Preparations for New Drug Development.Chinese Journal of Basic Medicine In Traditional Chinese
Medicine,1-13[2025-03-31].https://doi.org/10.19945/j.cnki.issn.1006-3250.20250116.001.
Medicine,1-13[2025-03-31].https://doi.org/10.19945/j.cnki.issn.1006-3250.20250116.001.
Feb
2025
2025
Gong Z, Hu M, Zhao G, Liang N, Zhang H, Li H, Che Q, Guo J, Song T, Wang Y, Shi N, Liu B. Therapeutic Effects of Alkaloids on Influenza: A Systematic Review and Meta-Analysis of Preclinical Studies. Int J Mol Sci. 2025 Feb 20;26(5):1823. doi: 10.3390/ijms26051823. PMID: 40076449; PMCID: PMC11899224.
Evidence-based guidelines
Jun
2020
2020
Novel coronavirus Pneumonia Collaborative Group, Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences . Evidence based traditional Chinese medicine treatment suggestions for novel coronavirus pneumonia. National Medical Journal of China,2020,100(21)：1611-1616.
Feb
2021
2021
Novel coronavirus Pneumonia Collaborative Group, Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences . Evidence based traditional Chinese medicine treatment suggestions for novel coronavirus pneumonia.
Jul
2021
2021
C. Tang et al., RIGHT for acupuncture: An extension of the RIGHT statement for clinical practice guidelines on acupuncture, Journal of Clinical Epidemiology, https://doi.org/10.1016/j.jclinepi.2021.05.021
Feb
2022
2022
YANG Dan, GUO Hai-ling, LI Xiao-hua, HAO Yu-fang, LIU Qian. Development of health science popularization works for rehabilitation of limb function in stroke patients. Chinese Journal of Nursing Education, 2022, 19(2):101-106.
Oct
2023
2023
YAN Lijiao, LIANG Ning, HU Ziteng,et al. Methodology for Developing Rapid and Living Guidelines of Traditional Chinese Medicine （RALIG-TCM）（Part 1）：Concept and Current Practice.Journal of Traditional Chinese Medicine,2024,65(03):269-274.DOI:10.13288/j.11-2166/r.2024.03.008.
Oct
2023
2023
ZHANG Yujing, YAN Lijiao, HU Ziteng,et al. Methodology for Developing Rapid and Living Guidelines of Traditional Chinese Medicine （RALIG-TCM）（Part 2）： Development Process and Key Steps during Preparation Stage. Journal of Traditional Chinese Medicine,2024,65(03):275-280.DOI:10.13288/j.11-2166/r.2024.03.009.
Oct
2023
2023
HU Ziteng, YAN Lijiao, ZHANG Yujing,et al. Methodology for Developing Rapid and Living Guidelines of Traditional Chinese Medicine （RALIG-TCM）（Part 3）： Rapid Evidence Collection， Integration and Recommendation Formation. Journal of Traditional Chinese Medicine,2024,65(03):281-286.DOI:10.13288/j.11-2166/r.2024.03.010.
Oct
2023
2023
YAN Lijiao, LIANG Ning, ZHANG Yujing,et al. Methodology for Developing Rapid and Living Guidelines of Traditional Chinese Medicine （RALIG-TCM）（Part 4）： Evidence Monitoring and Dynamic Updates. Journal of Traditional Chinese Medicine,2024,65(03):287-291.DOI:10.13288/j.11-2166/r.2024.03.011.
Jan
2024
2024
LIANG Ning,YAN Lijiao,ZHANG Yujing,et al.Methodology for the Development of Clinical Practice Guideline for Chinese Patent Medicine（Part 1）： Development Status and Characteristics[J].Journal of Traditional Chinese Medicine,2024,65(01):44-49. DOI: 10.13288/j.11-2166/r.2024.01.009.
Jan
2024
2024
CHEN Yaxin,LIANG Ning,YAN Lijiao,et al.Methodology for the Development of Clinical Practice Guidelines for Chinese Patent Medicine：2.Establishment of Guideline Working Group and Management of Conflict of Interests[J].Journal of Traditional Chinese Medicine,2024,65(01):50-54. DOI: 10.13288/j.11-2166/r.2024.01.010.
Jan
2024
2024
HU Ziteng,LIANG Ning,YAN Lijiao,et al.Methodology for the Development of Clinical Practice Guidelines for Chinese Patent Medicine（Part 3）： Identification of Clinical Questions[J].Journal of Traditional Chinese Medicine,2024,65(01):55-59. DOI: 10.13288/j.11-2166/r.2024.01.011.
Jan
2024
2024
ZHANG Fuqiang,YAN Lijiao,HU Ziteng,et al.Methodology for the Development of Clinical Practice Guidelines for Chinese Patent Medicine（Part 4）： Evidence Retrieval and Evaluation[J].Journal of Traditional Chinese Medicine,2024,65(01):60-65. DOI: 10.13288/j.11-2166/r.2024.01.012.
Jan
2024
2024
HU Ziteng,LIANG Ning,YAN Lijiao,et al.Methodology for the Development of Clinical Practice Guidelines for Chinese Patent Medicine（Part 5）： Retrieval and Synthesis of Key Information on Rational Drug Use[J].Journal of Traditional Chinese Medicine,2024,65(02):167-171. DOI: 10.13288/j.11-2166/r.2024.02.009.
Jan
2024
2024
ZHANG Yujing,LIANG Ning,YAN Lijiao,et al.Methodology for the Development of Clinical Practice Guidelines for Chinese Patent Medicine （Part 6）： Formation and Presentation of Recommendations[J].Journal of Traditional Chinese Medicine,2024,65(02):172-177. DOI: 10.13288/j.11-2166/r.2024.02.010.
Jan
2024
2024
7.HANG Yujing,ZHANG Fuqiang,YAN Lijiao,et al.Methodology for the Development of Clinical Practice Guidelines for Chinese Patent Medicine （Part 7）： Introduction and Interpretation of the Guideline Reporting Checklist[J].Journal of Traditional Chinese Medicine,2024,65(02):178-184. DOI: 10.13288/j.11-2166/r.2024.02.011.
Jan
2024
2024
ZHANG Fuqiang,HU Ziteng,ZHANG Yujing,et al.Methodology for the Development of Clinical Practice Guidelines for Chinese Patent Medicine （Part 8）： Quality Evaluation with AGREE Ⅱ and RIGHT[J].Journal of Traditional Chinese Medicine,2024,65(02):185-191. DOI: 10.13288/j.11-2166/r.2024.02.012.
Oct
2024
2024
YAN Lijiao, LIANG Ning, TIAN Ziyu,et al. Methodology for Developing Patient Guideline （1）：The Concept of Patient Guideline. Journal of Traditional Chinese Medicine,2024,65(20):2086-2101.DOI:10.13288/j.11-2166/r.2024.20.005.
Oct
2024
2024
YAN Lijiao, LIANG Ning, SHI Nannan,et al. Methodology for Developing Patient Guideline （2）：Process and Methodology. Journal of Traditional Chinese Medicine,2024,65(21):2194-2198.DOI:10.13288/j.11-2166/r.2024.21.005.
Oct
2024
2024
YAN Lijiao, LIANG Ning, ZHANG Haili,et al. Methodology for Developing Patient Guideline （3）：Reporting Frameworks and Presentation. Journal of Traditional Chinese Medicine,2024,65(22):2304-2309.DOI:10.13288/j.11-2166/r.2024.22.005.
Nov
2024
2024
BAI Zhenggang, ZHU Yumeng, CHEN Hao, et, al. One of the series of studies on evidence-based social intervention guidelines and standards: developing standards based on evidence-based concepts.New Medicine,2024,34(01):53-63.
Feb
2025
2025
SHI Nannan, XIONG Lei, MA Rong, et al. Clinical Application Guidelines of traditional Chinese patent medicines and simple preparations for Children’s Influenza (2024)[J/OL]. Journal of Traditional Chinese Medicine,1-21[2025-03-31].http://kns.cnki.net/kcms/detail/11.2166.R.20250208.1049.002.html.
Traditional Chinese Medicine Standards
Dec
2018
2018
Toxicity-reducing effect of compatibility of Tripterygium and licorice in animals: systematic review
LI Hui-zhen, LIU Bin, SHU Hai-yang, et al. Toxicity-reducing effect of compatibility of Tripterygium and licorice in animals: systematic review. China Journal of Chinese Materia Medica,2019,44(16):3512-3519.DOI:10.19540/j.cnki.cjcmm.20181214.002.
Mar
2020
2020
LI Huizhen, LIU Meijun, LIANG Ning, et al. Analysis of the citation of evidence in traditional Chinese medicine clinical pathways.Chinese Journal of Evidence-Based Medicine,2020,20(03):306-310.
Jul
2020
2020
LI Huizhen, HU Han, MENG Xiang, et al. Analysis of clinical irrational use of traditional Chinese patent medicines and simple preparations based on bibliometrics.Chinese Traditional Patent Medicine,2020,42(07):1954-1958.
Oct
2021
2021
LI Huizhen, WANG Jingya, GUO Yuna, et al. Qingfei Paidu Decoction （清 肺 排 毒 汤） Combined with Western Medicine Routine Treatment for Coro⁃navirus Disease 2019 with Hypertension:A Retrospective Study of 119 Cases.Journal of Traditional Chinese Medicine,2021,62(20):1795-1800.DOI:10.13288/j.11-2166/r.2021.20.009.
Oct
2021
2021
WANG Jingya, LI Huizhen, GUO Yuna, et al. Qingfei Paidu Decoction （清肺排毒汤） Combined with Western Routine Treatment for Elderly Patients with Coronavirus Disease 2019： A Retrospective Study.Journal of Traditional Chinese Medicine,2021,62(20):1788-1794.DOI:10.13288/j.11-2166/r.2021.20.008.
Apr
2022
2022
WANG Jing-ya, LI Hui-zhen, ZONG Xing-yu, et al. Analysis on the current situation, problems and countermeasures of international standardization of traditional Chinese medicine.China Journal of Traditional Chinese Medicine and Pharmacy,2022,37(04):1855-1859.
Aug
2022
2022
ZONG Xing-yu,LI Hui-zhen, WANG Jing-ya, et al. Research status of consortium standards and its enlightenment to the development of consortium standards of traditional Chinese medicine,Lishizhen Medicine and Materia Medica Research,2022,33(08):2037-2041.
Oct
2022
2022
GE Youwen, ZHENG Jian, ZONG Xingyu,et al. Association between Qingfei Paidu Granules （清肺排毒颗粒）Initiated at Different Timepoints and Clinical Outcomes in Asymptomatic COVID-19 Omicron Infection Cases.Journal of Traditional Chinese Medicine,2022,63(20):1952-1957.DOI:10.13288/j.11-2166/r.2022.20.010.
Dec
2022
2022
LI Huizhen, ZONG Xingyu, WANG Jingya, et al. Analysis and Considerations for Current Status of Association Standards in Traditional Chinese Medicine.ournal of Traditional Chinese Medicine,2022,63(24):2326-2331.DOI:10.13288/j.11-2166/r.2022.24.006.
Dec
2022
2022
Ya J W ,Yu X Z ,Hui G W , et al.3- to 24-month Follow-up on COVID-19 with Pulmonary Tuberculosis Survivors after Discharge: Results from a Prospective, Multicenter Study[J].Biomedical and Environmental Sciences,2022,35(12):1091-1099.
Feb
2023
2023
WANG Dingyi, WANG Jingya, LIU Yuqi, et al. Analysis and Suggestions on Application Status of Chinese ISO International Standards for Chinese Medicine.Chinese Journal of Basic Medicine In Traditional Chinese Medicine,2023,29(01):104-108.DOI:10.19945/j.cnki.issn.1006-3250.2023.01.039.
Feb
2023
2023
WANG Jingya, ZONG Xingyu, WANG Dingyi, et al. Study on Construction of Evaluation Index System for Implementation Effect of International Standards of Traditional Chinese Medicine.Chinese Journal of Basic Medicine In Traditional Chinese Medicine,2023,29(01):99-103.DOI:10.19945/j.cnki.issn.1006-3250.2023.01.038.
May
2023
2023
LI Huizhen, ZONG Xingyu, WANG Jingya, et al. Construction of Evaluation Index System of Group Standard of Traditional Chinese Medicine Based on Improved Delphi Method and Precedence Chart Method.Chinese Journal of Basic Medicine In Traditional Chinese Medicine,2023,29(05):775-780.DOI:10.19945/j.cnki.issn.1006-3250.2023.05.021.
May
2023
2023
WANG Jingya, ZONG Xingyu, WANG Dingyi, et al. Study on Evaluation of Implementation Effect of International Standards of Traditional Chinese Medicine Based on AHP-Fuzzy Comprehensive Evaluation Method.Chinese Journal of Basic Medicine In Traditional Chinese Medicine,2023,29(05):770-774.DOI:10.19945/j.cnki.issn.1006-3250.2023.05.030.
Oct
2023
2023
Wang, Yanping; Wang, Yongyan. Analysis of the development course of traditional Chinese medicine standardization and recommendations on future work. Guidelines and Standards in Chinese Medicine 1(1):p 1-8, October 2023. | DOI: 10.1097/gscm.0000000000000009
Oct
2023
2023
YU Xueyun,ZONG Xingyu, LI Huizhen, et al. Application of System of Consortium Standards Rating and Evaluation of Traditional Chinese Medicine: Evaluation of 90 Standards.Chinese Journal of Basic Medicine In Traditional Chinese Medicine,2024,30(01):71-75.DOI:10.19945/j.cnki.issn.1006-3250.20231008.001.
Oct
2023
2023
Li M Y ,Ya J W ,Yu X Z , et al.Treatment Outcomes in COVID-19 Patients with Brucellosis:Case Series in Heilongjiang and Systematic Review of Literature[J].Biomedical and Environmental Sciences,2023,36(10):930-939.
Jan
2024
2024
ZHAO Guozhen, GAO Ziheng, ZHAO Chen, et al. Methods and Challenges for Identifying and Controlling Confounding Factors in Traditional Chinese Medicine Observational Studies.Chinese Journal of Experimental Traditional Medical Formulae,2024,30(22):120-126.DOI:10.13422/j.cnki.syfjx.20240422.
Jan
2024
2024
ZONG Xingyu, LI Huizhen, ZHAO Xueyao, et al. Design of a Sampling Evaluation Scheme for the System of Consortium Standards Rating and Evaluation of Traditional Chinese Medicine (SCORE-TCM).Chinese Journal of Basic Medicine In Traditional Chinese Medicine,2024,30(01):66-70.DOI:10.19945/j.cnki.issn.1006-3250.2024.01.014.
Feb
2024
2024
ZHAO Guozhen, LI Huizhen, LIANG Ning, et al. Methodological Consideration on Combination Model of TCM Clinical Practice Guidelines and Real-world Study.Chinese Journal of Experimental Traditional Medical Formulae,2024,30(22):87-93.DOI:10.13422/j.cnki.syfjx.20240824.
Apr
2024
2024
ZONG Xingyu, WANG Dingyi, WANG Liying, et al. Interpretation of the System of Consortium Standards Rating and Evaluation of Traditional Chinese Medicine (SCORE-TCM).Chinese Journal of Basic Medicine In Traditional Chinese Medicine,2024,30(04):622-626.DOI:10.19945/j.cnki.issn.1006-3250.2024.04.015.
Aug
2024
2024
ZHAO Guozhen, ZONG Xingyu, ZHAOXueyao, et al. Interpretation of the Revised General Rules for the Diagnosis and Evaluation of Traditional Chinese Medicine Diseases and Efficacy, Chinese Journal of Basic Medicine In Traditional Chinese Medicine,2024,30(08):1294-1297.DOI:10.19945/j.cnki.issn.1006-3250.2024.08.014.
Oct
2024
2024
ZHAO Guozhen, ZONG Xingyu, ZHAO Xueyao, et al. Key Techniques and Methodological Considerations for Formation of Traditional Chinese Medicine Syndrome Classification Standards.Chinese Journal of Experimental Traditional Medical Formulae,2024,30(24):257-261.DOI:10.13422/j.cnki.syfjx.20250396.
Comprehensive evaluation
Mar
2021
2021
ZHANG Hai-li, JIAO Li-wen, LIANG Ning, et al. Construction of Multi Dimension and Multi Criteria Evaluation Index System for Superior Chinese Patent Medicines Based on Comprehensive Evaluation Method. Chinese Journal of Basic Medicine In Traditional Chinese Medicine, 2021,27(03):403-406.DOI:10.19945/j.cnki.issn.1006-3250.2021.03.012.
Jul
2022
2022
Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences, Dongzhimen Hospital of Beijing University of Chinese Medicine, Guidelines and Standards Research Center of Chinese Medical Association Publishing House, et al. Guideline for multi-dimensional and multi-criteria comprehensive evaluation of Chinese patent medicine. Chinese Journal of Evidence-Based Medicine,2022,22(07):751-755.
Jul
2022
2022
ZHANG Haili, LIANG Ning, CHEN Yaxin, et al. Interpretation of the guideline for multi-dimensional and multi-criteria comprehensive evaluation for Chinese patent medicine.Chinese Journal of Evidence-Based Medicine,2022,22(07):762-767.
Jul
2022
2022
ZHANG Haili, LIANG Ning, CHEN Yaxin, et al. Interpretation of the guideline for multi-dimensional and multi-criteria comprehensive evaluation for Chinese patent medicine.Chinese Journal of Evidence-Based Medicine,2022,22(07):762-767.Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences, Dongzhimen Hospital of Beijing University of Chinese Medicine, Guidelines and Standards Research Center of Chinese Medical Association Publishing House, et al. Preferred reporting items for comprehensive evaluation of Chinese patent medicine (PRICE-CPM). Chinese Journal of Evidence-Based Medicine,2022,22(07):745-750.
Jul
2022
2022
ZHANG Haili, JIAO Liwen, LIANG Ning, et al. Preferred reporting items for comprehensive evaluation of Chinese patent medicine (PRICE-CPM): elaboration and explanation. Chinese Journal of Evidence-Based Medicine,2022,22(07):756-761.
Aug
2022
2022
YANG Sihong, ZHAO Hui, LIANG Ning, et al. Technical Guidance Suggestions for Selection and Evaluation of Dominant Diseases in Traditional Chinese Medicine. Chinese Journal of Basic Medicine In Traditional Chinese Medicine, 2022,28(10):1595-1601.DOI:10.19945/j.cnki.issn.1006-3250.20220805.001.
Oct
2022
2022
WEN Hao, WANG Weili, ZHANG Haili, et al. Interpretation of guideline for multi-dimensional and multi-criteria evaluation for Chinese patent medicine: establishment of an evaluation model. Chinese Journal of Evidence-Based Medicine,2022,22(10):1196-1200.
May
2023
2023
LI Hongjiao, WANG Liying, ZHAO Hui, et al. Guidance Suggestions for Selection and Evaluation of Appropriate Technologies of Traditional Chinese Medicine.Chinese Journal of Basic Medicine In Traditional Chinese Medicine, 2023,29(05):781-784.DOI:10.19945/j.cnki.issn.1006-3250.2023.05.010.
Apr
2024
2024
ZHANG Haili, LIU Bin, WANG Weili, et al.Interpretation of the Guideline for Multi-dimensional and Multi-criteria Comprehensive Evaluation of Chinese Patent Medicine：weighting of evaluation indicators. China Pharmacy,2024,35(07):773-777.
Dec
2024
2024
Zhang Haili, Cao Wenjie, Yang Yijiu, et al. Design of Evidence-Based Decision-Making Pathway for the Selection of the National Essential Medicines List. Chinese Health Economics, 2025,44(01):15-19.
Dec
2024
2024
ZHANG Haili, CAO Wenjie, WANG Weili,et al. Interpretation of technical guiding principles for multidimensional and multi criteria comprehensive evaluation of traditional Chinese patent medicines and simple preparations: reliability and validity test of evaluation index systemChinese Journal of Basic Medicine In Traditional Chinese Medicine, 1-15[2025-03-31].https://doi.org/10.19945/j.cnki.issn.1006-3250.20241230.007.